Symbols

TOVX

Theriva Biologics·AMEX

--(--)

TOVX Profile

Theriva Biologics, Inc.

A diversified clinical-stage company that developing therapeutics for cancer

Industry

Pharmaceutical

Established Date

Listing Date

06/26/2007

Exchange

American Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.therivabio.com

Security Type

Common stock

Office address

9605 Medical Center Drive, Ste. 270, Rockville, MD 20850

Business

Introduction

Theriva Biologics, Inc. was originally established in 1986. It is a diversified clinical-stage company incorporated in Nevada in 2009 after a series of mergers and name changes. The company focuses on the development of therapies for the treatment of cancer and related diseases, and its lead tumor candidate, VCN-01, is a clinical-stage oncolytic adenovirus designed for intravenous and intravitreal delivery. It also owns other gastroenterology treatment assets.